<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/37EF6C9C-5F51-40DD-BED5-B792981BC119"><gtr:id>37EF6C9C-5F51-40DD-BED5-B792981BC119</gtr:id><gtr:name>Imperial Cancer Research Fund</gtr:name><gtr:address><gtr:line1>44 Lincoln's Inn Fields</gtr:line1><gtr:postCode>WC2A 3PX</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EDAF9688-F468-467B-9024-433291AFE684"><gtr:id>EDAF9688-F468-467B-9024-433291AFE684</gtr:id><gtr:name>Italian Foundation for Cancer Research</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F31D4A66-92AA-4002-BD5A-B0E539ACF08F"><gtr:id>F31D4A66-92AA-4002-BD5A-B0E539ACF08F</gtr:id><gtr:name>Mount Sinai Hospital (USA)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/11E604AE-3915-4673-AEA6-852F7D6BFFD8"><gtr:id>11E604AE-3915-4673-AEA6-852F7D6BFFD8</gtr:id><gtr:name>Wellcome Trust</gtr:name><gtr:address><gtr:line1>183 EUSTON ROAD</gtr:line1><gtr:city>LONDON</gtr:city><gtr:postCode>NW1  2BE</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F75103EE-8294-429F-BC9F-70CBED7DA893"><gtr:id>F75103EE-8294-429F-BC9F-70CBED7DA893</gtr:id><gtr:name>St Jude Children's Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A17A8BB4-BE35-43F2-9980-CF4FE2809E62"><gtr:id>A17A8BB4-BE35-43F2-9980-CF4FE2809E62</gtr:id><gtr:name>City University of New York</gtr:name><gtr:address><gtr:line1>695 Park Avenue</gtr:line1><gtr:line4>New York</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7A985B29-5945-4035-A62A-0CBF9C037FCA"><gtr:id>7A985B29-5945-4035-A62A-0CBF9C037FCA</gtr:id><gtr:name>Cold Spring Harbor Laboratory (CSHL)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9ECFC591-7C9D-49B7-9F6E-18FAD2D94172"><gtr:id>9ECFC591-7C9D-49B7-9F6E-18FAD2D94172</gtr:id><gtr:name>University of Lyon</gtr:name><gtr:address><gtr:line1>Caserne Sergent Blandan</gtr:line1><gtr:line2>37 Rue du Repos</gtr:line2><gtr:line3>69365</gtr:line3><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F5B83740-823A-461B-AEB6-0DCFED1739C8"><gtr:id>F5B83740-823A-461B-AEB6-0DCFED1739C8</gtr:id><gtr:name>Kyoto University</gtr:name><gtr:address><gtr:line1>Nishikyo-ku</gtr:line1><gtr:line2>Katsura Campus</gtr:line2><gtr:line4>Kyoto</gtr:line4><gtr:line5>Kyoto, 615-8540</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Japan</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/64BC5E73-972F-41E1-A12C-D97DC9BDFB93"><gtr:id>64BC5E73-972F-41E1-A12C-D97DC9BDFB93</gtr:id><gtr:name>MRC Clinical Sciences Centre</gtr:name><gtr:address><gtr:line1>Faculty of Medicine Imperial College</gtr:line1><gtr:line2>London Hammersmith Campus</gtr:line2><gtr:line3>Du Cane Road</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>W12 0NN</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/64BC5E73-972F-41E1-A12C-D97DC9BDFB93"><gtr:id>64BC5E73-972F-41E1-A12C-D97DC9BDFB93</gtr:id><gtr:name>MRC Clinical Sciences Centre</gtr:name><gtr:address><gtr:line1>Faculty of Medicine Imperial College</gtr:line1><gtr:line2>London Hammersmith Campus</gtr:line2><gtr:line3>Du Cane Road</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>W12 0NN</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/37EF6C9C-5F51-40DD-BED5-B792981BC119"><gtr:id>37EF6C9C-5F51-40DD-BED5-B792981BC119</gtr:id><gtr:name>Imperial Cancer Research Fund</gtr:name><gtr:address><gtr:line1>44 Lincoln's Inn Fields</gtr:line1><gtr:postCode>WC2A 3PX</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EDAF9688-F468-467B-9024-433291AFE684"><gtr:id>EDAF9688-F468-467B-9024-433291AFE684</gtr:id><gtr:name>Italian Foundation for Cancer Research</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F31D4A66-92AA-4002-BD5A-B0E539ACF08F"><gtr:id>F31D4A66-92AA-4002-BD5A-B0E539ACF08F</gtr:id><gtr:name>Mount Sinai Hospital (USA)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/11E604AE-3915-4673-AEA6-852F7D6BFFD8"><gtr:id>11E604AE-3915-4673-AEA6-852F7D6BFFD8</gtr:id><gtr:name>Wellcome Trust</gtr:name><gtr:address><gtr:line1>183 EUSTON ROAD</gtr:line1><gtr:city>LONDON</gtr:city><gtr:postCode>NW1  2BE</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F75103EE-8294-429F-BC9F-70CBED7DA893"><gtr:id>F75103EE-8294-429F-BC9F-70CBED7DA893</gtr:id><gtr:name>St Jude Children's Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A17A8BB4-BE35-43F2-9980-CF4FE2809E62"><gtr:id>A17A8BB4-BE35-43F2-9980-CF4FE2809E62</gtr:id><gtr:name>City University of New York</gtr:name><gtr:address><gtr:line1>695 Park Avenue</gtr:line1><gtr:line4>New York</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7A985B29-5945-4035-A62A-0CBF9C037FCA"><gtr:id>7A985B29-5945-4035-A62A-0CBF9C037FCA</gtr:id><gtr:name>Cold Spring Harbor Laboratory (CSHL)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9ECFC591-7C9D-49B7-9F6E-18FAD2D94172"><gtr:id>9ECFC591-7C9D-49B7-9F6E-18FAD2D94172</gtr:id><gtr:name>University of Lyon</gtr:name><gtr:address><gtr:line1>Caserne Sergent Blandan</gtr:line1><gtr:line2>37 Rue du Repos</gtr:line2><gtr:line3>69365</gtr:line3><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F5B83740-823A-461B-AEB6-0DCFED1739C8"><gtr:id>F5B83740-823A-461B-AEB6-0DCFED1739C8</gtr:id><gtr:name>Kyoto University</gtr:name><gtr:address><gtr:line1>Nishikyo-ku</gtr:line1><gtr:line2>Katsura Campus</gtr:line2><gtr:line4>Kyoto</gtr:line4><gtr:line5>Kyoto, 615-8540</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Japan</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/5B6834E3-C96A-4C2C-8722-FC2F29748C31"><gtr:id>5B6834E3-C96A-4C2C-8722-FC2F29748C31</gtr:id><gtr:firstName>Jesus</gtr:firstName><gtr:surname>Gil</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U120085810"><gtr:id>EAC51E32-E013-4C95-B5E7-400723AA0D27</gtr:id><gtr:title>Cell Proliferation</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U120085810</gtr:grantReference><gtr:abstractText>Cancer is one of the leading causes of mortality in Britain and in the whole world. Cancer research is an especially complex issue, as what we call cancer is a set of more than 100 different diseases. In addition from the genetic perspective, every tumour presents more than 6 different genes altered. In this way, hundreds of genes have been proposed to be cancer genes. The prediction is that many other genes remain to be identified. Moreover, to really discern which genes are causing and which ones are just altered as a mere consequence of cancer, we have to identify the function of these genes.|The final goal of our laboratory is to identify novel cancer genes and understand how they work. This will be the basis for novel treatment, diagnostic and/or prognosis of cancer. |To this end, we use a simple approach. Using normal cells that we can culture, we introduce to them a collection of genes and aim to identify the ones that confer cancer-characteristics to normal cells. By testing randomly big collections of genes, our goal is to identify novel genes with a direct role in cancer. Also, the way in which we design our experiments implies that we detect only those genes which have a functional relation with cancer.</gtr:abstractText><gtr:technicalSummary>The ultimate goal of our group is to identify novel genes involved in cancer and analyze how they are related with the genetic networks regulating cell proliferation. Normal cells have a limited ability to proliferate. When primary cells reach this limit or upon the expression of some oncogenes, they cannot growth anymore, suffering an irreversible growth arrest termed senescence.||Specifically our laboratory works in understanding senescence as it is a tumour suppressor mechanism that hinders tumour progression but also since we can use it as a model system, as often the genes identified in this way have a role in cancer or other human diseases. We use normal cells (different human and mouse cells of epithelial and fibroblast origin) and perform genetic screenings to identify genes regulating their lifespan. We use cDNA, shRNA and microRNA retroviral or lentiviral libraries in our screenings. As we already mentioned, we are interesting in identifying new genes or genetic elements regulating senescence and possibly impacting in cancer. Current experiments have identified novel candidates which a role in senescence, and we are performing genetic and molecular biology-based experiments to understand how they relate to the core pathways controlling senescence and oncogenesis.||In the past, using genetic screenings, we identified the role of glycolytic enzymes in senescence and cancer and how the Polycomb group (PcG) gene CBX7 modulates cellular lifespan by repressing the transcription of the Ink4a/Arf locus and therefore interfering with the Rb and p53 pathways. An area of continuous interest in our laboratory is to further understand the mechanism of action of CBX7 and which is its function under physiological and pathological conditions. We are pursuing that goals through the characterization of CBX7-interacting proteins that we have identified in yeast-2-hybrid screenings and by tandem affinity purification (TAP) followed by Mass Spectroscopy (MS). We are characterizing three interesting candidates flagged through those approaches. ||On the other hand, we have developed appropriate models through our collaboration with Scott Lowe (CSHL, NY, USA) to understand the role of CBX7 in cancer and in normal and pathological circumstances.</gtr:technicalSummary><gtr:fund><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>8757641</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>St Jude Children's Hospital</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Surgery</gtr:department><gtr:description>Reprogramming</gtr:description><gtr:id>7532EC74-472A-463A-BF7A-9B38A27AC88D</gtr:id><gtr:impact>19696146</gtr:impact><gtr:outcomeId>96841738816-2</gtr:outcomeId><gtr:partnerContribution>researchresearchresearchresearch</gtr:partnerContribution><gtr:piContribution>research</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Mount Sinai Hospital (USA)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Reprogramming</gtr:description><gtr:id>CB3E7701-4E9D-4F98-8440-A817E9CDA8A3</gtr:id><gtr:impact>19696146</gtr:impact><gtr:outcomeId>96841738816-1</gtr:outcomeId><gtr:partnerContribution>researchresearchresearchresearch</gtr:partnerContribution><gtr:piContribution>research</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Italian Foundation for Cancer Research</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:department>FIRC Institute of Molecular Oncology Foundation</gtr:department><gtr:description>Immunohistochemistry</gtr:description><gtr:id>15C50D03-776B-46DB-8EF2-42449B88A027</gtr:id><gtr:impact>18555777</gtr:impact><gtr:outcomeId>095CD4E3847-2</gtr:outcomeId><gtr:partnerContribution>researchresearchresearch</gtr:partnerContribution><gtr:piContribution>Analysis of gene expression in Cancer. Resulted in a Cell paper</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cold Spring Harbor Laboratory (CSHL)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Animal models</gtr:description><gtr:id>65BB8CE7-7B95-436B-8B8A-F432700345D1</gtr:id><gtr:impact>17374722</gtr:impact><gtr:outcomeId>7A705C65A35-1</gtr:outcomeId><gtr:partnerContribution>research</gtr:partnerContribution><gtr:piContribution>research</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Kyoto</gtr:collaboratingOrganisation><gtr:country>Japan</gtr:country><gtr:description>Glycolysis</gtr:description><gtr:id>20EA0EF8-7002-4D5E-BD53-14282D070FFB</gtr:id><gtr:impact>17128414</gtr:impact><gtr:outcomeId>5FA60706CEF-1</gtr:outcomeId><gtr:partnerContribution>research</gtr:partnerContribution><gtr:piContribution>research</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cancer Research UK</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Cancer Research UK London Research Institute (LRI)</gtr:department><gtr:description>JMJD3</gtr:description><gtr:id>FF4D76F5-B1CF-41F3-8D82-A50F0FB47FC7</gtr:id><gtr:impact>19451218</gtr:impact><gtr:outcomeId>5D903A40FA0-1</gtr:outcomeId><gtr:partnerContribution>researchresearch</gtr:partnerContribution><gtr:piContribution>Research</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Reproductive and Developmental Biology</gtr:department><gtr:description>Reprogramming</gtr:description><gtr:id>DE63343C-3DAB-496B-BD8D-72AD13C19BFB</gtr:id><gtr:impact>19696146</gtr:impact><gtr:outcomeId>96841738816-3</gtr:outcomeId><gtr:partnerContribution>researchresearchresearchresearch</gtr:partnerContribution><gtr:piContribution>research</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>City University of New York (CUNY)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Immunohistochemistry</gtr:description><gtr:id>3C62DB83-E05B-4724-8F67-D7A518CAD420</gtr:id><gtr:impact>18555777</gtr:impact><gtr:outcomeId>095CD4E3847-1</gtr:outcomeId><gtr:partnerContribution>researchresearchresearch</gtr:partnerContribution><gtr:piContribution>Analysis of gene expression in Cancer. Resulted in a Cell paper</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Wellcome Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Wellcome Trust Centre for Stem Cell Research</gtr:department><gtr:description>Reprogramming</gtr:description><gtr:id>1FB80BEB-8EDA-4880-B80E-CA2C88A6F7B9</gtr:id><gtr:impact>19696146</gtr:impact><gtr:outcomeId>96841738816-4</gtr:outcomeId><gtr:partnerContribution>researchresearchresearchresearch</gtr:partnerContribution><gtr:piContribution>research</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Lyon</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Immunohistochemistry</gtr:description><gtr:id>DEEB9E16-2356-4155-9A1C-038C5DFF0053</gtr:id><gtr:impact>18555777</gtr:impact><gtr:outcomeId>095CD4E3847-3</gtr:outcomeId><gtr:partnerContribution>researchresearchresearch</gtr:partnerContribution><gtr:piContribution>Analysis of gene expression in Cancer. Resulted in a Cell paper</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Mount Sinai Hospital (USA)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>JMJD3</gtr:description><gtr:id>D7B94D3D-ED31-4E82-A835-C478C4152F66</gtr:id><gtr:impact>19451218</gtr:impact><gtr:outcomeId>5D903A40FA0-2</gtr:outcomeId><gtr:partnerContribution>researchresearch</gtr:partnerContribution><gtr:piContribution>Research</gtr:piContribution><gtr:sector>Hospitals</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Interview for Onda CEro spanish radio</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>023A37C1-45FB-45C8-A268-E99087AD3D37</gtr:id><gtr:impact>Interview about science and Spanish scientist abroad

general audience noticed</gtr:impact><gtr:outcomeId>FANW45PA31e</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interviews EMBO YIP award</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>44621198-ADF6-4B2C-B81F-B374F3298D19</gtr:id><gtr:impact>Several interviews to Spanish Media (newspapers Vanguardia, Publico; News Agencies: Efe; Radios: Radio Nacional) regarding the award of the EMBO YIP

It was all over the press and highlighted the CSC and the funding of the MRC in making the science progress. Also gave opportunity to highlighht our research</gtr:impact><gtr:outcomeId>A8A187E3DF2</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview for BBC news website</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>A3E9DC47-378B-4A90-ACC2-6E3D30ED82B8</gtr:id><gtr:impact>Interview to BBC news to comment on a recent paper published by a group in the States

Audience noticed</gtr:impact><gtr:outcomeId>Xs6mfef98Eb</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview Spanish television TVE for night nws</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>E46B4B4B-2E14-45F7-9AD7-17931057D210</gtr:id><gtr:impact>interview about science for the 9 news on Spanish TVE

Interest about science</gtr:impact><gtr:outcomeId>rytFtYNwGeW</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press Release CXCR2 paper</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>31A61E21-84B6-4D15-B3CF-1B2E7CE6B088</gtr:id><gtr:impact>Press release about our 2008 Cell paper on the role of CXCR2 in Senescence. It was also picked by the MRC in its 2008/2009 annual brochure

Disseminate the importance of research</gtr:impact><gtr:outcomeId>4933D2A495B</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>221713</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK Project Grant (Identification and characterisation of microRNAs with oncogenic properties)</gtr:description><gtr:end>2009-12-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>9575F7B9-3CF0-4703-BD7D-77117194662B</gtr:id><gtr:outcomeId>A7484A3FECB0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>172429</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF Centre for Excellent (main PI Sian Harding)</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>WHCF_P47532 subproject 3 to P47352 (shared with Prof A. Fisher)</gtr:fundingRef><gtr:id>796F256A-6D85-423D-B896-FA01887B932B</gtr:id><gtr:outcomeId>JSoJiNM6YCN</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>125000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC/BHF Cardiovascuular stem cell research strategic fund grant</gtr:description><gtr:end>2013-11-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>D6FDE4CE-4B92-4FDD-BAC8-F1340258B197</gtr:id><gtr:outcomeId>FKmkzz6PZaN1</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>122894</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Developmental Gap Funding (Screening for small compounds modulating senescence)</gtr:description><gtr:end>2011-12-02</gtr:end><gtr:fundingOrg>MRC Technology (MRCT)</gtr:fundingOrg><gtr:id>A113ED89-6ED3-4B62-82E9-CB5097B4FB7C</gtr:id><gtr:outcomeId>36F46BF76FA0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>40000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EMBO Young Investigator Programme (Exploiting cellular senescence to identify novel cancer genes)</gtr:description><gtr:end>2011-12-02</gtr:end><gtr:fundingOrg>European Molecular Biology Organisation</gtr:fundingOrg><gtr:id>A555C4DE-D90C-4332-984F-EBF6C880442A</gtr:id><gtr:outcomeId>33F5A7FA8650</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>Portugal, Portuguese Republic</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Foundation for Science and Technology</gtr:department><gtr:description>FCT portuguese PhD fellowship</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>New University of Lisbon</gtr:fundingOrg><gtr:id>5F724EE3-CFDC-45F4-920F-80473C2184D7</gtr:id><gtr:outcomeId>YjYBR2gAh6v0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>24000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EMBO LT fellowship</gtr:description><gtr:end>2010-03-02</gtr:end><gtr:fundingOrg>European Molecular Biology Organisation</gtr:fundingOrg><gtr:id>C8115F9B-024B-4755-991D-0B8285D639B5</gtr:id><gtr:outcomeId>rYnf7KxpTpY0</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2009-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>129021</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK Project:Oncogene-induced senescence as a route to tumour suppressor discovery</gtr:description><gtr:end>2009-10-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>F6020E5A-ABD8-45C0-9678-ED378CCE4A80</gtr:id><gtr:outcomeId>05AA3274B020</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EMBO LT fellowship</gtr:description><gtr:end>2015-03-02</gtr:end><gtr:fundingOrg>European Molecular Biology Organisation</gtr:fundingOrg><gtr:id>6C2BE6C8-6BC6-4172-87A8-13F8B0E3A236</gtr:id><gtr:outcomeId>aEQDDy7vm9E</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2013-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>22000</gtr:amountPounds><gtr:country>France, French Republic</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ARC Fellowship (Role of senescence in limiting prostate cancer progression)</gtr:description><gtr:end>2010-03-02</gtr:end><gtr:fundingOrg>International Agency for Research on Cancer (IARC)</gtr:fundingOrg><gtr:id>7A332596-571A-428E-A140-CFAECA6EA4D1</gtr:id><gtr:outcomeId>89D52133CA10</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>20000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Centennary Awards</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>A304947C-C85C-4518-83D1-1B33166FE85E</gtr:id><gtr:outcomeId>XKfErSn1xUh</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>125000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>marie curie fellowship</gtr:description><gtr:end>2013-03-02</gtr:end><gtr:fundingOrg>Marie Sklodowska-Curie Actions</gtr:fundingOrg><gtr:id>22B61B5D-9516-487B-953A-41D6C43F7B93</gtr:id><gtr:outcomeId>hsDEzxzJg3H0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>125000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC/BHF Cardiovascuular stem cell research strategic fund grant</gtr:description><gtr:end>2013-11-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>F29DB9B7-D63F-4F90-BA3F-3364C26E933A</gtr:id><gtr:outcomeId>FKmkzz6PZaN0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>210206</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>AICR Project Grant (Identification of genes controlling replicative senescence in human epithelial cells and cancer)</gtr:description><gtr:end>2011-03-02</gtr:end><gtr:fundingOrg>Association for International Cancer Research (AICR)</gtr:fundingOrg><gtr:id>5A2541AF-0C9D-4F45-AD71-E5876E19EDCD</gtr:id><gtr:outcomeId>5C635C116D80</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>45000</gtr:amountPounds><gtr:country>Spain, Kingdom of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Fundaci&amp;oacute;n Ram&amp;oacute;n Areces Fellowship (Regulation of Polycomb group gene expression)</gtr:description><gtr:end>2008-10-02</gtr:end><gtr:fundingOrg>Ram?n Areces Foundation</gtr:fundingOrg><gtr:id>313DDE51-F4B1-4A66-A0BB-A5C02E0A068D</gtr:id><gtr:outcomeId>DC6896528130</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>9980</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Hammersmith Hospital Research Committee, Project Grant, MicroRNA expression profile associated with oncogene-induced senescence</gtr:description><gtr:end>2007-07-02</gtr:end><gtr:fundingOrg>Imperial College Healthcare NHS Trust</gtr:fundingOrg><gtr:id>399BDCBD-A2AC-423E-A593-D97390195393</gtr:id><gtr:outcomeId>AC138B52BE20</gtr:outcomeId><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>90000</gtr:amountPounds><gtr:country>Portugal, Portuguese Republic</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Foundation for Science and Technology</gtr:department><gtr:description>FCT, Project Grant, Identification of genes controlling senescence in mouse embryonic fibroblasts</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>New University of Lisbon</gtr:fundingOrg><gtr:id>6354EEB6-E306-4373-8C28-B929D84182CA</gtr:id><gtr:outcomeId>06471D55BBD0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>C64664A4-3096-4D30-A159-500B8EF80F4E</gtr:id><gtr:title>Immunization with recombinant DNA and modified vaccinia virus Ankara (MVA) vectors delivering PSCA and STEAP1 antigens inhibits prostate cancer progression.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ab05696bcf34884b8057b2de2b3a6883"><gtr:id>ab05696bcf34884b8057b2de2b3a6883</gtr:id><gtr:otherNames>Krupa M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>pm_15465_25_21182993</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B8B66FB3-FAF8-429C-9705-F397C5DDA1A5</gtr:id><gtr:title>Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b52519c54df31a7bcc2e32070c9259b"><gtr:id>6b52519c54df31a7bcc2e32070c9259b</gtr:id><gtr:otherNames>Yap KL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>T1rsU1D7Aj5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B155AA09-4063-4D07-9C44-1441F7214749</gtr:id><gtr:title>A genetic screen identifies topoisomerase 1 as a regulator of senescence.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/944f0b423958929f226d7ff5b6481ece"><gtr:id>944f0b423958929f226d7ff5b6481ece</gtr:id><gtr:otherNames>Humbert N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>6CAFC9B9119</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C8FEC93-4DB4-436A-90BA-6C24319F6AC1</gtr:id><gtr:title>An adaptive signaling network in melanoma inflammatory niches confers tolerance to MAPK signaling inhibition.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76d3241d4f3c90046b5a1dfc29873dfc"><gtr:id>76d3241d4f3c90046b5a1dfc29873dfc</gtr:id><gtr:otherNames>Young HL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>5a7cb8fe71c400.94819769</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D564BFA7-341B-45D9-B6E5-512E4E904DA7</gtr:id><gtr:title>Co-regulation of senescence-associated genes by oncogenic homeobox proteins and polycomb repressive complexes.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2698db37f13851560a6e4e3aa5a78457"><gtr:id>2698db37f13851560a6e4e3aa5a78457</gtr:id><gtr:otherNames>Martin N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>pm_15465_25_24067365</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA920935-25E1-46E3-99E4-BB4345B1FF53</gtr:id><gtr:title>MicroRNA regulation of Cbx7 mediates a switch of Polycomb orthologs during ESC differentiation.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/82395b0107b4adda97dd8e226c727f1b"><gtr:id>82395b0107b4adda97dd8e226c727f1b</gtr:id><gtr:otherNames>O'Loghlen A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn><gtr:outcomeId>pm_15465_25_22226354</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED65E473-C3CA-4FC1-B00A-FBEA6C19FD7F</gtr:id><gtr:title>Functional crosstalk between Bmi1 and MLL/Hoxa9 axis in establishment of normal hematopoietic and leukemic stem cells.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9eacb28e9921d908dae42d7b09175479"><gtr:id>9eacb28e9921d908dae42d7b09175479</gtr:id><gtr:otherNames>Smith LL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn><gtr:outcomeId>c7bboVEgW1z</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A206C433-BD65-4078-B21B-4EAE01045A85</gtr:id><gtr:title>A role for CXCR2 in senescence, but what about in cancer?</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4dbb1e05246fa8516bb83f92f5a02314"><gtr:id>4dbb1e05246fa8516bb83f92f5a02314</gtr:id><gtr:otherNames>Acosta JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>24C0EE74E34</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A118E52-DA0A-4CFE-B561-384133AE7DF4</gtr:id><gtr:title>Ageing as developmental decay: insights from p16(INK4a.).</gtr:title><gtr:parentPublicationTitle>Trends in molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2698db37f13851560a6e4e3aa5a78457"><gtr:id>2698db37f13851560a6e4e3aa5a78457</gtr:id><gtr:otherNames>Martin N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1471-4914</gtr:issn><gtr:outcomeId>54614a99414647.04914912</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>802AC6E8-1569-4565-895D-6B4257DF13D0</gtr:id><gtr:title>TRIM28/KAP1 regulates senescence.</gtr:title><gtr:parentPublicationTitle>Immunology letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5ea6f1e4cd01dde23dd2d356244b6f44"><gtr:id>5ea6f1e4cd01dde23dd2d356244b6f44</gtr:id><gtr:otherNames>Santos J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0165-2478</gtr:issn><gtr:outcomeId>54614a99bda176.73738647</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>636C97EF-5269-48EC-88C1-1263C65611B2</gtr:id><gtr:title>Netrin-1 regulates somatic cell reprogramming and pluripotency maintenance.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e132591aa581b6bc28fc54df4b99bd3c"><gtr:id>e132591aa581b6bc28fc54df4b99bd3c</gtr:id><gtr:otherNames>Ozmadenci D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>56d582386f8f61.47027132</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1C27F296-31BF-486B-AD35-03CE3D860468</gtr:id><gtr:title>Epigenetic regulation of the INK4b-ARF-INK4a locus: in sickness and in health.</gtr:title><gtr:parentPublicationTitle>Epigenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aaf34ca7652593d1159744967f7f1d38"><gtr:id>aaf34ca7652593d1159744967f7f1d38</gtr:id><gtr:otherNames>Popov N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1559-2294</gtr:issn><gtr:outcomeId>SB8s6eKWehk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6AA7984F-6A8D-49B9-81A4-4AB27726B6BF</gtr:id><gtr:title>A common metabolic profile shared between murine ES cells and primary cells bypassing senescence</gtr:title><gtr:parentPublicationTitle>Medical Hypotheses and Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5420e59728702e219ab195009368aaeb"><gtr:id>5420e59728702e219ab195009368aaeb</gtr:id><gtr:otherNames>Kondoh, H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:outcomeId>F8F72B57A03</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>609FB6CA-D61D-4C3F-B837-0D3B27714EA7</gtr:id><gtr:title>Mitochondria and senescence: new actors for an old play.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/07104789896031f091d9e119e242dff9"><gtr:id>07104789896031f091d9e119e242dff9</gtr:id><gtr:otherNames>Herranz N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>56d5832369fb28.09662256</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D8D0FF7-060D-4877-BC38-A44627F5FDF0</gtr:id><gtr:title>Synthetic lethal targeting of oncogenic transcription factors in acute leukemia by PARP inhibitors.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/956e5e925663f9adfbdbc86fa3afeb1a"><gtr:id>956e5e925663f9adfbdbc86fa3afeb1a</gtr:id><gtr:otherNames>Esposito MT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>56d58322aa0a03.17926330</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>51C07768-B73B-409F-AA97-EE2D604C892D</gtr:id><gtr:title>Chemokine signaling via the CXCR2 receptor reinforces senescence.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4dbb1e05246fa8516bb83f92f5a02314"><gtr:id>4dbb1e05246fa8516bb83f92f5a02314</gtr:id><gtr:otherNames>Acosta JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>B605D027F4F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>11E625C5-B7E5-4BAE-8321-200D4C8C0BB7</gtr:id><gtr:title>Regulation of heterochromatin transcription by Snail1/LOXL2 during epithelial-to-mesenchymal transition.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ccec5c556ce831cf63a22a447ca7e3b"><gtr:id>1ccec5c556ce831cf63a22a447ca7e3b</gtr:id><gtr:otherNames>Millanes-Romero A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>pm_15465_25_24239292</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0CCADED3-F80B-4F8C-8B28-0412385AAF0E</gtr:id><gtr:title>ESCs require PRC2 to direct the successful reprogramming of differentiated cells toward pluripotency.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/50db7f4e36915c9d8bf3172def5ab796"><gtr:id>50db7f4e36915c9d8bf3172def5ab796</gtr:id><gtr:otherNames>Pereira CF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn><gtr:outcomeId>PLRDKCtw5nK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>89A8A1F6-E9EA-44C1-A85C-D14DC65191E5</gtr:id><gtr:title>Cyclin-dependent kinase inhibitor p21 controls adult neural stem cell expansion by regulating Sox2 gene expression.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/321e27f721fde3396cdfeaa4d1c8793f"><gtr:id>321e27f721fde3396cdfeaa4d1c8793f</gtr:id><gtr:otherNames>Marqu?s-Torrej?n M?</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn><gtr:outcomeId>pm_15465_25_23260487</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30E8B8A2-5C50-4C91-8021-C96C93977B21</gtr:id><gtr:title>Expression profiling of nuclear receptors in breast cancer identifies TLX as a mediator of growth and invasion in triple-negative breast cancer.</gtr:title><gtr:parentPublicationTitle>Oncotarget</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26471a8f1b859c77a6224ea72862a20a"><gtr:id>26471a8f1b859c77a6224ea72862a20a</gtr:id><gtr:otherNames>Lin ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1949-2553</gtr:issn><gtr:outcomeId>56d58238c19198.24980528</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30E0799A-ADE8-403B-82C2-4DAC5CEB4A1F</gtr:id><gtr:title>The nuclear receptor NR2E1/TLX controls senescence.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/82395b0107b4adda97dd8e226c727f1b"><gtr:id>82395b0107b4adda97dd8e226c727f1b</gtr:id><gtr:otherNames>O'Loghlen A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>54614a99192d14.64358360</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>61E54C94-A1BD-4CF4-8D2A-AF2F09B92645</gtr:id><gtr:title>Ncoa3 functions as an essential Esrrb coactivator to sustain embryonic stem cell self-renewal and reprogramming.</gtr:title><gtr:parentPublicationTitle>Genes &amp; development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/882562f15b5c89786eb8b64374aabb6b"><gtr:id>882562f15b5c89786eb8b64374aabb6b</gtr:id><gtr:otherNames>Percharde M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0890-9369</gtr:issn><gtr:outcomeId>pm_15465_25_23019124</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46252A4C-0EE1-4AEE-8E5E-3A9BD6C570C5</gtr:id><gtr:title>A high glycolytic flux supports the proliferative potential of murine embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Antioxidants &amp; redox signaling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/68161173082344bfe6fa5b7e71a89a61"><gtr:id>68161173082344bfe6fa5b7e71a89a61</gtr:id><gtr:otherNames>Kondoh H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1523-0864</gtr:issn><gtr:outcomeId>8CD108D660C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3492D51F-0D9A-46B6-AA02-076F21A077B3</gtr:id><gtr:title>Several distinct polycomb complexes regulate and co-localize on the INK4a tumor suppressor locus.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/67c749d627f6a6bccbe386923cc5a048"><gtr:id>67c749d627f6a6bccbe386923cc5a048</gtr:id><gtr:otherNames>Maertens GN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>03F3355679B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E89F07D-9D5E-4630-9D78-3F035B537EBD</gtr:id><gtr:title>CBX7 and miR-9 are part of an autoregulatory loop controlling p16(INK) (4a).</gtr:title><gtr:parentPublicationTitle>Aging cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/82395b0107b4adda97dd8e226c727f1b"><gtr:id>82395b0107b4adda97dd8e226c727f1b</gtr:id><gtr:otherNames>O'Loghlen A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1474-9718</gtr:issn><gtr:outcomeId>56d5832246cba1.81015629</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D0502760-6EA6-4899-BE02-289BDDE98133</gtr:id><gtr:title>Ageing: Out with the old.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b4f353f66776ae9b3b0dce9c1ed013df"><gtr:id>b4f353f66776ae9b3b0dce9c1ed013df</gtr:id><gtr:otherNames>Gil J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>56d583230b8b52.75617845</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>626B8A4D-FEE9-4DF2-BDEF-0E4A38605563</gtr:id><gtr:title>Controlling secretion to limit chemoresistance.</gtr:title><gtr:parentPublicationTitle>Genes &amp; development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/20cdf4335a3a1f2e2e81376c2035e181"><gtr:id>20cdf4335a3a1f2e2e81376c2035e181</gtr:id><gtr:otherNames>Georgilis A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0890-9369</gtr:issn><gtr:outcomeId>589a3ad1c7fd66.99026394</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7683261B-E322-488E-82B6-EB9DAEC9D88F</gtr:id><gtr:title>Induced pluripotent stem cells and senescence: learning the biology to improve the technology.</gtr:title><gtr:parentPublicationTitle>EMBO reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70a23e19c84745d189f8858e37a99e99"><gtr:id>70a23e19c84745d189f8858e37a99e99</gtr:id><gtr:otherNames>Banito A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1469-221X</gtr:issn><gtr:outcomeId>MX4HEexEw4F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FBBCF706-ED3F-446B-B33B-5B1B64099CB5</gtr:id><gtr:title>Control of senescence by CXCR2 and its ligands.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4dbb1e05246fa8516bb83f92f5a02314"><gtr:id>4dbb1e05246fa8516bb83f92f5a02314</gtr:id><gtr:otherNames>Acosta JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>152D87CD0C1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>399180DD-67F1-4E16-92E0-C667010C8A40</gtr:id><gtr:title>Regulation of ploidy and senescence by the AMPK-related kinase NUAK1.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/944f0b423958929f226d7ff5b6481ece"><gtr:id>944f0b423958929f226d7ff5b6481ece</gtr:id><gtr:otherNames>Humbert N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>D82BDCBBEEF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E71376AE-8B59-4EC5-B9A5-CB9E1B19D05C</gtr:id><gtr:title>Oncogenic RAS-induced senescence in human primary thyrocytes: molecular effectors and inflammatory secretome involved.</gtr:title><gtr:parentPublicationTitle>Oncotarget</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4fec06658d3973162cc05232eeb82aed"><gtr:id>4fec06658d3973162cc05232eeb82aed</gtr:id><gtr:otherNames>Vizioli MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1949-2553</gtr:issn><gtr:outcomeId>54614a99842bd7.21251860</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B14EB3E-B4D6-4D5B-810A-334F24E1C56B</gtr:id><gtr:title>HMGB2 holds the key to the senescence-associated secretory phenotype.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8a0a075e93064eb39764b5355cd5b0c4"><gtr:id>8a0a075e93064eb39764b5355cd5b0c4</gtr:id><gtr:otherNames>Guerrero A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn><gtr:outcomeId>585d379a92d198.11720950</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A11656CF-207B-43A7-822D-8E229E8D2DFC</gtr:id><gtr:title>Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS.</gtr:title><gtr:parentPublicationTitle>Genes &amp; development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31a8a619a073df1e56ca62fa0e7a3d85"><gtr:id>31a8a619a073df1e56ca62fa0e7a3d85</gtr:id><gtr:otherNames>Barradas M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0890-9369</gtr:issn><gtr:outcomeId>F7CF6F94CDB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B553920-0483-432F-891E-1ADAE16B2B45</gtr:id><gtr:title>TORn about SASP regulation.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/07104789896031f091d9e119e242dff9"><gtr:id>07104789896031f091d9e119e242dff9</gtr:id><gtr:otherNames>Herranz N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>56d58322d70f08.73672920</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC2F8E84-3B05-4C97-829A-FFDD745AA1DA</gtr:id><gtr:title>Senescence impairs successful reprogramming to pluripotent stem cells.</gtr:title><gtr:parentPublicationTitle>Genes &amp; development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70a23e19c84745d189f8858e37a99e99"><gtr:id>70a23e19c84745d189f8858e37a99e99</gtr:id><gtr:otherNames>Banito A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0890-9369</gtr:issn><gtr:outcomeId>B4BCF8672DF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57B1F38C-A83F-4D0A-B68E-00F5AD4FF175</gtr:id><gtr:title>Disturbed flow promotes endothelial senescence via a p53-dependent pathway.</gtr:title><gtr:parentPublicationTitle>Arteriosclerosis, thrombosis, and vascular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63c5b3c174b6ae4fd7b65cfda1549843"><gtr:id>63c5b3c174b6ae4fd7b65cfda1549843</gtr:id><gtr:otherNames>Warboys CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1079-5642</gtr:issn><gtr:outcomeId>pm_15465_25_24651677</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9109CAF5-071A-48EC-BD8B-CD8438602F97</gtr:id><gtr:title>Unbiased characterization of the senescence-associated secretome using SILAC-based quantitative proteomics.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4dbb1e05246fa8516bb83f92f5a02314"><gtr:id>4dbb1e05246fa8516bb83f92f5a02314</gtr:id><gtr:otherNames>Acosta JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>pm_15465_25_23296658</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8287AD9F-4E92-4CBE-AFE2-1410BB79E254</gtr:id><gtr:title>Mitochondrial Dysfunction Meets Senescence.</gtr:title><gtr:parentPublicationTitle>Trends in biochemical sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/37f24ed43b6a8cc35d51a2d144ab2986"><gtr:id>37f24ed43b6a8cc35d51a2d144ab2986</gtr:id><gtr:otherNames>Gallage S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0968-0004</gtr:issn><gtr:outcomeId>56d5832335fc27.81820699</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>100F49EF-D09D-4757-BDD0-8A1EC25D711B</gtr:id><gtr:title>The homeoprotein SIX1 controls cellular senescence through the regulation of p16INK4A and differentiation-related genes.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/727babe6e2d0972c640514b02f3f228c"><gtr:id>727babe6e2d0972c640514b02f3f228c</gtr:id><gtr:otherNames>Adrados I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>56d583227d5521.17695539</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E092CC97-1E2E-4F35-B884-AD784B7E1778</gtr:id><gtr:title>Senescence and aging: Causes, consequences, and therapeutic avenues.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e2486887006d9ee171ecb577ac6db9b2"><gtr:id>e2486887006d9ee171ecb577ac6db9b2</gtr:id><gtr:otherNames>McHugh D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn><gtr:outcomeId>5a2fd6a74e6c59.21004776</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B63B70BB-942A-4527-A8AA-702607992389</gtr:id><gtr:title>PRC1 complex diversity: where is it taking us?</gtr:title><gtr:parentPublicationTitle>Trends in cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b4f353f66776ae9b3b0dce9c1ed013df"><gtr:id>b4f353f66776ae9b3b0dce9c1ed013df</gtr:id><gtr:otherNames>Gil J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0962-8924</gtr:issn><gtr:outcomeId>54614a99e5a9b1.81429470</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>00B681D0-374A-48AA-A69C-A58B7A9E1F38</gtr:id><gtr:title>A complex secretory program orchestrated by the inflammasome controls paracrine senescence.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4dbb1e05246fa8516bb83f92f5a02314"><gtr:id>4dbb1e05246fa8516bb83f92f5a02314</gtr:id><gtr:otherNames>Acosta JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn><gtr:outcomeId>pm_15465_25_23770676</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>37DB8F43-E7AF-4D96-92B5-2E9DE7CBFD28</gtr:id><gtr:title>Molecular basis for androgen independency in prostate cancer</gtr:title><gtr:parentPublicationTitle>Cancer Therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93a573cf2316bd178bd1531dc11fb497"><gtr:id>93a573cf2316bd178bd1531dc11fb497</gtr:id><gtr:otherNames>Gil Jesus</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:outcomeId>EFE51496C15</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8027AFD6-1782-41A7-90D4-E5A19D7CE1C3</gtr:id><gtr:title>Senescence: a new weapon for cancer therapy.</gtr:title><gtr:parentPublicationTitle>Trends in cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4dbb1e05246fa8516bb83f92f5a02314"><gtr:id>4dbb1e05246fa8516bb83f92f5a02314</gtr:id><gtr:otherNames>Acosta JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0962-8924</gtr:issn><gtr:outcomeId>pm_15465_25_22245068</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C34E95BA-F14D-4768-89DD-E9BF60037505</gtr:id><gtr:title>Coupling shRNA screens with single-cell RNA-seq identifies a dual role for mTOR in reprogramming-induced senescence.</gtr:title><gtr:parentPublicationTitle>Genes &amp; development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/354aa6e9a3779f182e5fb3417509355e"><gtr:id>354aa6e9a3779f182e5fb3417509355e</gtr:id><gtr:otherNames>Aarts M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0890-9369</gtr:issn><gtr:outcomeId>5a7cb8fde9d408.74311600</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1FB9E3BC-2941-48F6-B856-FB313F2C505A</gtr:id><gtr:title>Mouse polycomb proteins bind differentially to methylated histone H3 and RNA and are enriched in facultative heterochromatin.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/04a0869796782f63cacd5a0993133e1b"><gtr:id>04a0869796782f63cacd5a0993133e1b</gtr:id><gtr:otherNames>Bernstein E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0270-7306</gtr:issn><gtr:outcomeId>1F7FAD663D1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ADBC4D6C-865B-4231-9570-2A86EC050D86</gtr:id><gtr:title>Stem cell senescence drives age-attenuated induction of pituitary tumours in mouse models of paediatric craniopharyngioma.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e827dc598ed105eaad6a1457fa1df704"><gtr:id>e827dc598ed105eaad6a1457fa1df704</gtr:id><gtr:otherNames>Mario Gonzalez-Meljem J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5a7cb8fe310b93.37067312</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>270C21C2-5330-45C1-8231-63FB42E1ACA8</gtr:id><gtr:title>Mitogen-activated protein kinase signaling mediates phosphorylation of polycomb ortholog Cbx7.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/12451cb67c8a048c442608bc21ff002d"><gtr:id>12451cb67c8a048c442608bc21ff002d</gtr:id><gtr:otherNames>Wu HA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_15465_25_24194518</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9430BCF3-377D-475C-ADBD-DE800CDBA024</gtr:id><gtr:title>Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action.</gtr:title><gtr:parentPublicationTitle>Microbiology and molecular biology reviews : MMBR</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/891431e611aacc51f3a55c8796e18568"><gtr:id>891431e611aacc51f3a55c8796e18568</gtr:id><gtr:otherNames>Garc?a MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1092-2172</gtr:issn><gtr:outcomeId>9EA848034E3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2EFAD6C-BA39-44D1-83E2-950D84FD85D6</gtr:id><gtr:title>Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Molecular cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b4f353f66776ae9b3b0dce9c1ed013df"><gtr:id>b4f353f66776ae9b3b0dce9c1ed013df</gtr:id><gtr:otherNames>Gil J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1471-0072</gtr:issn><gtr:outcomeId>191D624267D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>71DDDA6A-31F5-423A-9E60-0C6181274947</gtr:id><gtr:title>The M-type receptor PLA2R regulates senescence through the p53 pathway.</gtr:title><gtr:parentPublicationTitle>EMBO reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a0f0bb70697bf9d0e42a4584ea73b82"><gtr:id>9a0f0bb70697bf9d0e42a4584ea73b82</gtr:id><gtr:otherNames>Augert A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1469-221X</gtr:issn><gtr:outcomeId>8017DC27388</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3DC8131-D25F-4A03-BB1E-FF9C5BA3387C</gtr:id><gtr:title>Induction of fibroblast senescence generates a non-fibrogenic myofibroblast phenotype that differentially impacts on cancer prognosis.</gtr:title><gtr:parentPublicationTitle>Aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d5c5431d1c8749df431cb44dc8c46368"><gtr:id>d5c5431d1c8749df431cb44dc8c46368</gtr:id><gtr:otherNames>Mellone M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1945-4589</gtr:issn><gtr:outcomeId>589a3b00005278.40462111</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5631BC96-6DDA-499A-B3F7-7253CC010AA7</gtr:id><gtr:title>Premature senescence in cells from patients with autosomal recessive hypercholesterolemia (ARH): evidence for a role for ARH in mitosis.</gtr:title><gtr:parentPublicationTitle>Arteriosclerosis, thrombosis, and vascular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d6b5b320fef2f1f45ba3a8b56ca0de7"><gtr:id>4d6b5b320fef2f1f45ba3a8b56ca0de7</gtr:id><gtr:otherNames>Sun XM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1079-5642</gtr:issn><gtr:outcomeId>q3pszhY6F1x</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB02B311-B919-4FBB-B270-5E057055504F</gtr:id><gtr:title>SWI/SNF regulates a transcriptional program that induces senescence to prevent liver cancer.</gtr:title><gtr:parentPublicationTitle>Genes &amp; development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/517c2d10b04e77ca599976adb7d8e33b"><gtr:id>517c2d10b04e77ca599976adb7d8e33b</gtr:id><gtr:otherNames>Tordella L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0890-9369</gtr:issn><gtr:outcomeId>585d389c8a3e09.64173949</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6355B8C8-6579-4C74-8E74-24D12DF220B1</gtr:id><gtr:title>Role of the chromobox protein CBX7 in lymphomagenesis.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e41f412c1a4efff7f25f7ae0acafa4bb"><gtr:id>e41f412c1a4efff7f25f7ae0acafa4bb</gtr:id><gtr:otherNames>Scott CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>0B242D7DA34</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F6E84B7-4DA9-44C7-824C-5DC2C7D32EC0</gtr:id><gtr:title>DGCR8-mediated disruption of miRNA biogenesis induces cellular senescence in primary fibroblasts.</gtr:title><gtr:parentPublicationTitle>Aging cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/747a1bbd2264137fe5329bb2b784721b"><gtr:id>747a1bbd2264137fe5329bb2b784721b</gtr:id><gtr:otherNames>G?mez-Cabello D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1474-9718</gtr:issn><gtr:outcomeId>pm_15465_25_23773483</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97BF335D-6CAF-4481-8DD0-01983435DEB7</gtr:id><gtr:title>Protection from oxidative stress by enhanced glycolysis; a possible mechanism of cellular immortalization.</gtr:title><gtr:parentPublicationTitle>Histology and histopathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/68161173082344bfe6fa5b7e71a89a61"><gtr:id>68161173082344bfe6fa5b7e71a89a61</gtr:id><gtr:otherNames>Kondoh H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0213-3911</gtr:issn><gtr:outcomeId>48C432E4865</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E790E6DF-2BD1-4E02-A8F8-6D4F5B0E0788</gtr:id><gtr:title>Senescence surveillance of pre-malignant hepatocytes limits liver cancer development.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/66ab3905d3e55a05de0485449cdba733"><gtr:id>66ab3905d3e55a05de0485449cdba733</gtr:id><gtr:otherNames>Kang TW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>LX4fyfR7wGo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C0292D2-4BA2-4C00-A305-EDCE2D5C0811</gtr:id><gtr:title>Primary cilia and senescence: a sensitive issue.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/37f24ed43b6a8cc35d51a2d144ab2986"><gtr:id>37f24ed43b6a8cc35d51a2d144ab2986</gtr:id><gtr:otherNames>Gallage S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>56d5823811c370.02791211</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1796816E-E9EB-4A3B-A9FB-FE1EBD2763F1</gtr:id><gtr:title>The cerebral cavernous malformation 3 gene is necessary for senescence induction.</gtr:title><gtr:parentPublicationTitle>Aging cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8a0a075e93064eb39764b5355cd5b0c4"><gtr:id>8a0a075e93064eb39764b5355cd5b0c4</gtr:id><gtr:otherNames>Guerrero A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1474-9718</gtr:issn><gtr:outcomeId>56d582384013b5.24073508</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3656A6D6-1B82-4160-A45C-6942E0AD9500</gtr:id><gtr:title>Interplay between Homeobox proteins and Polycomb repressive complexes in p16INK4a regulation.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2698db37f13851560a6e4e3aa5a78457"><gtr:id>2698db37f13851560a6e4e3aa5a78457</gtr:id><gtr:otherNames>Martin N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>pm_15465_25_23455154</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D961682-62A4-4D2F-96C0-469A8F8A6EF6</gtr:id><gtr:title>The methyl-CpG-binding protein MECP2 is required for prostate cancer cell growth.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/21e56c264bd77d773e439fd1dcf71edf"><gtr:id>21e56c264bd77d773e439fd1dcf71edf</gtr:id><gtr:otherNames>Bernard D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>E472C2FB4BE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F85D850-F939-4B0D-B090-DAC3FA838897</gtr:id><gtr:title>mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/07104789896031f091d9e119e242dff9"><gtr:id>07104789896031f091d9e119e242dff9</gtr:id><gtr:otherNames>Herranz N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn><gtr:outcomeId>56d583220e8663.70452547</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6DD249D3-2BD9-451F-9416-BB843EF521A4</gtr:id><gtr:title>Cancer: The Transforming Power of Cell Competition.</gtr:title><gtr:parentPublicationTitle>Current biology : CB</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b4f353f66776ae9b3b0dce9c1ed013df"><gtr:id>b4f353f66776ae9b3b0dce9c1ed013df</gtr:id><gtr:otherNames>Gil J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0960-9822</gtr:issn><gtr:outcomeId>56d58323961256.27136987</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U120085810</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>